Brain Injury

Selegiline Reverses Anxiety & Memory Impairment in Amyloid Beta-Induced Alzheimers Model Rats (2024 Study)

by

The study demonstrated that selegiline (SEL) improves memory performance, reduces anxiety, and modulates oxidative stress in an Alzheimer’s disease (AD) rat model. Highlights: Memory Improvements: SEL administration improved recognition memory, spatial memory, and passive avoidance memory in AD rats. Anxiety Reduction: SEL significantly reduced anxiety-like behavior in AD rats, as evidenced by performance in the …

Read more

Repurposing Antipsychotics & Antidepressants to Treat Glioblastoma (2024 Study)

by

Repurposing antipsychotics and antidepressants with favorable safety profiles and blood-brain barrier permeability shows promise for glioblastoma (GBM) treatment, primarily through disrupting lysosomal function and inducing cell death. Highlights: Mechanism of Action: The studied antipsychotics and antidepressants induce GBM cell death by disrupting lysosomal function, leading to lysosomal membrane rupture. PTEN Sensitivity: GBMs with intact PTEN …

Read more

Type 2 Diabetes Linked to Lower Cerebral Blood Flow (CBF) in Hippocampus (2024 Study)

by

This study shows that type 2 diabetes causes decreased blood flow and changes in neural activity in specific parts of the hippocampus, which may initially compensate for cognitive decline but deteriorate with worsening diabetes. Highlights: Decreased Perfusion: Patients with type 2 diabetes have lower blood flow in the right hippocampal CA1, DG, and subiculum areas. …

Read more

1-Year Post-COVID Neuropsychiatric Symptoms: Fatigue, Cognition, Anxiety, Depression, Headache, Dizziness (2024 Study)

by

A study found that adults recovering from their first COVID-19 infection more than 1-year ago have higher levels of fatigue and other chronic neuropsychiatric symptoms, influenced by vaccination status and socioeconomic factors. Highlights: Adults who had their first COVID-19 infection over 1-year ago reported significantly higher fatigue levels compared to those who never had COVID-19 …

Read more

BPC-157 Peptide May Treat CNS Disorders: Stroke, Schizophrenia, Spinal Cord Injury

by

The naturally occurring peptide BPC 157 shows potential to treat stroke, schizophrenia symptoms, and spinal cord injury in animal models. Key facts: BPC 157 rapidly counteracted stroke damage and led to full recovery of memory, coordination and movement in rats. The peptide alleviated schizophrenia-like symptoms and catalepsy in rodent models by modulating dopamine, glutamate and …

Read more

TBI Risks in Military Occupations: Combat Roles More Vulnerable

by

Traumatic brain injury (TBI) has been called the “signature injury” of recent conflicts in Iraq and Afghanistan. TBIs are concerning because they can cause long-term issues like headaches, memory problems, and trouble thinking clearly. A new study looked at which military jobs put service members most at risk for TBIs. It found that certain combat-related …

Read more

Endless Echoes: Concussions Ignite Chronic Brain Inflammation in Athletes

by

Researchers have found signs of ongoing inflammation in the brains of athletes still experiencing concussion symptoms months or years after their injury, according to a new study published in Journal of Neuroinflammation. The findings suggest the concussion triggered chronic neuroinflammation that may be contributing to their persistent symptoms. Key Facts: The study examined athletes who …

Read more

+ Load more